December 16, 2019

Biophytis Receives FDA Approval to Proceed with the MYODA Program for Clinical Development of Sarconeos (BIO101) in Patients with Duchenne Muscular Dystrophy (DMD). Read the Press Release

December 9, 2019

Biophytis Presents Preliminary Analysis of SARA-OBS study at the 12th Annual Congress of The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) in Berlin, Germany. Read the Press Release

16 april 2019

Biophytis announces the release of the 2018 Annual Financial Report and the departure of Jean-Gérard Galvez from the Board of Directors. Read the Press Release